Blue Wave Therapeutics is a privately owned Swiss-based biotechnology company, founded in 2021 with the goal to develop treatments aiming at significantly improving survival of cancer patients based on its novel biopolymer-radionuclide targeting platform.
Company Details
- Employees
- 7
- Founded
- 2021
- Address
- Breitenstrasse 85 C, Wilen,wollerau 8832,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Radionuclide therapy, Biopolymers, Brain Cancer, Solid tumors, Alpha emitters, Cancer, Oncology, Biotechnology, Alginate, Nanoparticles, Targeted therapy, Local therapy.
- HQ
- Wilen, Wollerau
Blue Wave Therapeutics Questions
Blue Wave Therapeutics's website is http://www.bluewavetherapeutics.com
Blue Wave Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/blue-wave-therapeutics
Blue Wave Therapeutics has
7 employees.
View email and phone details for 7
employees at Blue Wave Therapeutics.
Blue Wave Therapeutics's industry is
Biotechnology Research
Blue Wave Therapeutics's top competitors are
Pincell Srl,
Noema Pharma,
Genxbioscience Ag,
Cis Biopharma,
Thor Medical Asa,
Alivion,
Clee Medical,
Elionova Ag,
Augmedi,
Translation-X.
Blue Wave Therapeutics's categories are Biotechnology Research
Blue Wave Therapeutics's founding year is 2021
